Oligonucleotid zur Detektion von Polymorphismen des Rezeptor des epidermalen Wachstumsfaktors Exon 19 und Verwendung davon
Anmelder: ARKRAY, Inc. 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP2520666
- Aktenzeichen
- EP12166238
- Anmeldetag
- 30. April 2012
- Veröffentlichung
- 7. März 2018
- Erteilung
- 7. März 2018
- Rechtsraum
- EP
- IPC
- C12Q1/68
Abstract
An oligonucleotide for a test for detecting a polymorphism of EGFR exon 19, the oligonucleotide being at least one selected from the group consisting of a P1 oligonucleotide and a P1' oligonucleotide, the P1 oligonucleotide having a 3' end subjected to an extension inhibition treatment, which has an identity of at least 80% with respect to a base sequence including at least the 115th to the 123rd bases of the base sequence indicated in SEQ ID NO: 1 and has a length of from 9 to 80 bases; and the P1' oligonucleotide having a 3' end subjected to an extension inhibition treatment, which hybridizes under stringent conditions with the complementary strand of a base sequence including at least the 115th to the 123rd bases of the base sequence indicated in SEQ ID NO: 1 and having a length of from 9 to 80 bases.
Anmelder
- Firma
- ARKRAY, Inc.
- Land
- 🇯🇵 Japan
Japanisches Unternehmen mit Sitz in Kyoto, das medizinische Diagnosegeräte herstellt, insbesondere Blutzuckermessgeräte und klinische Labordiagnostik.
793 Patente in unserer Datenbank
Fachgebiete
-
Dehns
Dehns · London